Screening and testing for Alzheimer’s disease and related dementias are limited despite the benefits of early detection, according to responses from a recent survey.
A report on the survey was published last month in Alzheimer’s & Dementia, and announced on Feb. 20 by the University of Michigan School of Public Health.